Shigetaka Mimori

Title: Shigetaka Mimori: Innovator in Norovirus Research

Introduction

Shigetaka Mimori is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of infectious diseases, particularly in the study of norovirus. His innovative work has led to advancements in research methodologies and potential therapeutic applications.

Latest Patents

Mimori holds a patent for a "Cultured transgenic cell allowing growth of norovirus, and use thereof." This invention addresses the stagnation of research on norovirus by providing a cultured transgenic cell or a transgenic animal that enables the growth of murine norovirus (MNV) across the barrier of host specificity in mammalian cells. The patent outlines a screening method utilizing the cultured transgenic cell or the transgenic animal, which has been instrumental in advancing norovirus-related drug screening methods.

Career Highlights

Throughout his career, Shigetaka Mimori has held significant positions, including Director-General of the National Institute of Infectious Diseases and roles at Denka Company Limited. His leadership in these organizations has facilitated important research initiatives and collaborations in the field of infectious diseases.

Collaborations

Mimori has worked alongside notable colleagues such as Kei Haga and Akira Fujimoto. Their collaborative efforts have contributed to the advancement of research in norovirus and related fields.

Conclusion

Shigetaka Mimori's innovative contributions to norovirus research and his leadership in prominent institutions highlight his impact on the scientific community. His work continues to pave the way for advancements in understanding and combating infectious diseases.